CLINICAL_TRIALS
trial_result
· 2018-11-02
Clinical Trial Update: Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes Mellitus [Phase 1]
Summary
Phase 1 trial update evaluating the effect of a fixed pramlintide:insulin dose ratio on postprandial glucose in type 1 diabetes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: AstraZeneca | Conditions: Type 1 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2018-11-02